Cytokinetics | CYTK - Loan Capital

Stock Price
62.11
Daily Change
1.87 3.10%
Monthly
-5.06%
Yearly
45.25%
Q1 Forecast
61.24

Cytokinetics reported $158.75M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 52.43B 1.33B Sep/2025
Bayer EUR 32.71B 1B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cytokinetics USD 158.75M 554.3M Sep/2025
Eisai JPY 134.75B 34.91B Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Geron USD 119.26M 273K Sep/2025
Halozyme Therapeutics USD 800.07M 709.03M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025